AICDA and lymphoma: Analyzing the DLBCL outcome influenced by concurrent AID, Koff et al. [27] demonstrated a decreased lymphoma-related mortality in patients with SLE and DLBCL compared with DLBCL patients without AID, but this difference was not statistically significant.